| Sep'18 | May'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|
Operating costs | ||||||
- | - | 2,559 | 3,658 | 473 | 76 | 5 |
Operating income | ||||||
- | - | -2,559 | -3,658 | -473 | -76 | -5 |
Interest income | ||||||
- | - | 733 | 591 | 572 | 180 | 0 |
Change in fair value of deferred underwriting fee liability | ||||||
- | - | 4 | -66 | -91 | 167 | 0 |
Unrealized loss on marketable securities held in Trust Account | ||||||
- | - | -29 | 7 | -38 | 28 | 0 |
Net income | ||||||
12,190 | 8,587 | -1,851 | -3,126 | -31 | 299 | -5 |
Net earnings per share | ||||||
Weighted average shares outstanding, basic and diluted | ||||||
- | - | 11,730 | 12,912 | 11,730 | 8,314 | 5,250 |
Basic and diluted net loss per ordinary share | ||||||
- | - | -0.20 | -0.40 | -0.04 | 0.04 | 0.00 |